By Professor Glenda Halliday

Journal articles

Wiseman JA; Turner CP; Faull RLM; Halliday GM; Dieriks BV, 2025, 'Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy', Translational Neurodegeneration, 14, http://dx.doi.org/10.1186/s40035-025-00469-6

Beauchamp LC; Ellett LJ; Juan SMA; Liu XM; Hunt CPJ; Parish CL; Jacobson LH; Shepherd CE; Halliday GM; Bush AI; Vella LJ; Finkelstein DI; Barnham KJ, 2025, 'Evidence of COMT dysfunction in the olfactory bulb in Parkinson’s disease', Acta Neuropathologica, 149, http://dx.doi.org/10.1007/s00401-025-02861-y

Lewis SJG; Sue CM; Cooper A; Halliday GM, 2025, 'Future is now: An Australasian perspective on disease-modifying trials in Parkinson's and prodromal disease', BMJ Neurology Open, 7, http://dx.doi.org/10.1136/bmjno-2025-001070

Suzuki M; Nilsson S; Shepherd CE; Zammit I; Suryana E; Mueller N; Halliday G; Wang X; Symeonides C; Dunlop S; Mueller JF, 2025, 'Number of Carbons Is a Critical Parameter for Accumulation of Per- and Polyfluoroalkyl Substances in the Human Brain', Environmental Science and Technology, 59, pp. 3366 - 3375, http://dx.doi.org/10.1021/acs.est.4c09458

Lam I; Ndayisaba A; Lewis AJ; Fu YH; Sagredo GT; Kuzkina A; Zaccagnini L; Celikag M; Sandoe J; Sanz RL; Vahdatshoar A; Martin TD; Morshed N; Ichihashi T; Tripathi A; Ramalingam N; Oettgen-Suazo C; Bartels T; Boussouf M; Schäbinger M; Hallacli E; Jiang X; Verma A; Tea C; Wang Z; Hakozaki H; Yu X; Hyles K; Park C; Wang X; Theunissen TW; Wang H; Jaenisch R; Lindquist S; Stevens B; Stefanova N; Wenning G; van de Berg WDJ; Luk KC; Sanchez-Pernaute R; Gómez-Esteban JC; Felsky D; Kiyota Y; Sahni N; Yi SS; Chung CY; Stahlberg H; Ferrer I; Schöneberg J; Elledge SJ; Dettmer U; Halliday GM; Bartels T; Khurana V, 2025, 'Erratum: Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions (Neuron (2024) 112(17) (2886–2909.e16), (S0896627324004094), (10.1016/j.neuron.2024.06.002))', Neuron, 113, pp. 637, http://dx.doi.org/10.1016/j.neuron.2025.01.018

Wiseman JA; Halliday GM; Dieriks BV, 2025, 'Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy.', Brain, http://dx.doi.org/10.1093/brain/awaf030

Espay AJ; Lees AJ; Cardoso F; Frucht SJ; Erskine D; Sandoval IM; Bernal-Conde LD; Sturchio A; Imarisio A; Hoffmann C; Montemagno KT; Milovanovic D; Halliday GM; Manfredsson FP, 2025, 'The α-synuclein seed amplification assay: Interpreting a test of Parkinson's pathology', Parkinsonism and Related Disorders, 131, http://dx.doi.org/10.1016/j.parkreldis.2024.107256

Ndayisaba A; Halliday GM; Khurana V, 2025, 'Multiple System Atrophy: Pathology, Pathogenesis, and Path Forward', Annual Review of Pathology: Mechanisms of Disease, 20, pp. 245 - 273, http://dx.doi.org/10.1146/annurev-pathmechdis-051122-104528

Fu YH; Adler GL; Youssef P; Phan K; Halliday GM; Dzamko N; Kim WS, 2025, 'Human Endogenous Retrovirus K in Astrocytes Is Altered in Parkinson's Disease', Movement Disorders, http://dx.doi.org/10.1002/mds.30128

Wiseman JA; Halliday GM; Dieriks BV, 2024, 'A new seed amplification assay to diagnose multiple system atrophy', The Lancet Neurology, 23, pp. 1175 - 1176, http://dx.doi.org/10.1016/S1474-4422(24)00428-9

Naaldijk Y; Fernández B; Fasiczka R; Fdez E; Leghay C; Croitoru I; Kwok JB; Boulesnane Y; Vizeneux A; Mutez E; Calvez C; Destée A; Taymans JM; Aragon AV; Yarza AB; Padmanabhan S; Delgado M; Alcalay RN; Chatterton Z; Dzamko N; Halliday G; Ruiz-Martínez J; Chartier-Harlin MC; Hilfiker S, 2024, 'A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells', npj Parkinson's Disease, 10, http://dx.doi.org/10.1038/s41531-023-00624-8

Fu YH; Pickford R; Galper J; Phan K; Wu P; Li H; Kim YB; Dzamko N; Halliday GM; Kim WS, 2024, 'A protective role of ABCA5 in response to elevated sphingomyelin levels in Parkinson’s disease', npj Parkinson's Disease, 10, http://dx.doi.org/10.1038/s41531-024-00632-2

Weiss F; Hughes L; Fu Y; Bardy C; Halliday GM; Dzamko N, 2024, 'Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson’s model', Translational Neurodegeneration, 13, http://dx.doi.org/10.1186/s40035-024-00448-3

Balcomb K; Johnston C; Kavanagh T; Halliday GM; Wisniewski T; Sunde M; Drummond E, 2024, 'Basic Science and Pathogenesis', Alzheimer's & dementia : the journal of the Alzheimer's Association, 20, pp. e090551, http://dx.doi.org/10.1002/alz.090551

Kovacs GG; Grinberg LT; Halliday G; Alafuzoff I; Dugger BN; Murayama S; Forrest SL; Martinez-Valbuena I; Tanaka H; Kon T; Yoshida K; Jaunmuktane Z; Spina S; Nelson PT; Gentleman S; Alegre-Abarrategui J; Serrano GE; Paes VR; Takao M; Wakabayashi K; Uchihara T; Yoshida M; Saito Y; Kofler J; Rodriguez RD; Gelpi E; Attems J; Crary JF; Seeley WW; Duda JE; Keene CD; Woulfe J; Munoz D; Smith C; Lee EB; Neumann M; White CL; McKee AC; Thal DR; Jellinger K; Ghetti B; Mackenzie IRA; Dickson DW; Beach TG, 2024, 'Biomarker-Based Approach to α-Synucleinopathies: Lessons from Neuropathology', Movement Disorders, 39, pp. 2173 - 2179, http://dx.doi.org/10.1002/mds.30028

de Boer SCM; Fenoglio C; Fumagalli GG; Riedl L; Matis S; Chatterton Z; Rue I; Landin-Romero R; van der Lee SJ; Sommer P; Grimmer T; Diehl-Schmid J; Teunissen C; Galimberti D; Halliday GM; Ducharme S; Piguet O; Pijnenburg YAL, 2024, 'Clinical Manifestations', Alzheimer's & dementia : the journal of the Alzheimer's Association, 20, pp. e087999, http://dx.doi.org/10.1002/alz.087999

Luo H; Gustavsson EK; Macpherson H; Dominik N; Zhelcheska K; Montgomery K; Anderson C; Yau WY; Efthymiou S; Turner C; DeTure M; Dickson DW; Josephs KA; Revesz T; Lashley T; Halliday G; Rowe DB; McCann E; Blair I; Lees AJ; Tienari PJ; Suomalainen A; Molina-Porcel L; Kovacs GG; Gelpi E; Hardy J; Haltia MJ; Tucci A; Jaunmuktane Z; Ryten M; Houlden H; Chen Z, 2024, 'Letter to the editor on: Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions by Park et al. (2022)', Acta Neuropathologica Communications, 12, http://dx.doi.org/10.1186/s40478-023-01706-7

Jensen NM; Fu YH; Betzer C; Li H; Elfarrash S; Shaib AH; Krah D; Vitic Z; Reimer L; Gram H; Buchman V; Denham M; Rizzoli SO; Halliday GM; Jensen PH, 2024, 'MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity', npj Parkinson's Disease, 10, http://dx.doi.org/10.1038/s41531-024-00841-9

Wiseman JA; Fu YH; Faull RLM; Turner CP; Curtis MA; Halliday GM; Dieriks BV, 2024, 'N-terminus α-synuclein detection reveals new and more diverse aggregate morphologies in multiple system atrophy and Parkinson’s disease', Translational Neurodegeneration, 13, http://dx.doi.org/10.1186/s40035-024-00456-3

Galper J; Mori G; McDonald G; Ahmadi Rastegar D; Pickford R; Lewis SJG; Halliday GM; Kim WS; Dzamko N, 2024, 'Prediction of motor and non-motor Parkinson’s disease symptoms using serum lipidomics and machine learning: a 2-year study', npj Parkinson's Disease, 10, http://dx.doi.org/10.1038/s41531-024-00741-y

Balcomb K; Johnston C; Kavanagh T; Leitner D; Schneider J; Halliday G; Wisniewski T; Sunde M; Drummond E, 2024, 'SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation', Acta Neuropathologica, 148, http://dx.doi.org/10.1007/s00401-024-02819-6

Burré J; Edwards RH; Halliday G; Lang AE; Lashuel HA; Melki R; Murayama S; Outeiro TF; Papa SM; Stefanis L; Woerman AL; Surmeier DJ; Kalia LV; Takahashi R; Olsen A; Surmeier DJ; Bayram E; Chaing HL; Lee JY; Peall K; Lohmann K; Zeuner K; Cornejo-Olivas M; Calabresi P; Przedborski S, 2024, 'Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis', Movement Disorders, 39, pp. 1663 - 1678, http://dx.doi.org/10.1002/mds.29897

Lam I; Ndayisaba A; Lewis AJ; Fu YH; Sagredo GT; Kuzkina A; Zaccagnini L; Celikag M; Sandoe J; Sanz RL; Vahdatshoar A; Martin TD; Morshed N; Ichihashi T; Tripathi A; Ramalingam N; Oettgen-Suazo C; Bartels T; Boussouf M; Schäbinger M; Hallacli E; Jiang X; Verma A; Tea C; Wang Z; Hakozaki H; Yu X; Hyles K; Park C; Wang X; Theunissen TW; Wang H; Jaenisch R; Lindquist S; Stevens B; Stefanova N; Wenning G; van de Berg WDJ; Luk KC; Sanchez-Pernaute R; Gómez-Esteban JC; Felsky D; Kiyota Y; Sahni N; Yi SS; Chung CY; Stahlberg H; Ferrer I; Schöneberg J; Elledge SJ; Dettmer U; Halliday GM; Bartels T; Khurana V, 2024, 'Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions', Neuron, 112, pp. 2886 - 2909.e16, http://dx.doi.org/10.1016/j.neuron.2024.06.002

Sagredo GT; Tanglay O; Shahdadpuri S; Fu YH; Halliday GM, 2024, '⍺-Synuclein levels in Parkinson's disease – Cell types and forms that contribute to pathogenesis', Experimental Neurology, 379, http://dx.doi.org/10.1016/j.expneurol.2024.114887

Carroll J; McCann H; Halliday GM; Kwok JB; Dobson-Stone C; Shepherd CE, 2024, 'Poly-GA immunohistochemistry is a reliable tool for detecting C9orf72 hexanucleotide repeat expansions', Brain Pathology, 34, http://dx.doi.org/10.1111/bpa.13216

Clarke AJ; Brodtmann A; Irish M; Mowszowski L; Radford K; Naismith SL; Mok VCT; Kiernan MC; Halliday GM; Ahmed RM, 2024, 'Risk factors for the neurodegenerative dementias in the Western Pacific region', The Lancet Regional Health - Western Pacific, 50, http://dx.doi.org/10.1016/j.lanwpc.2024.101051

Liao S-C; Kano K; Phanse S; Nguyen M; Margolis E; Fu Y; Meng J; Moutaoufik MT; Chatterton Z; Aoki H; Simms J; Hsieh I; Suteja F; Sei Y; Huang EJ; McAvoy K; Manfredi G; Halliday G; Babu M; Nakamura K, 2024, 'CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism.', bioRxiv, http://dx.doi.org/10.1101/2024.08.30.610586

Manzoni C; Kia DA; Ferrari R; Leonenko G; Costa B; Saba V; Jabbari E; Tan MM; Albani D; Alvarez V; Alvarez I; Andreassen OA; Angiolillo A; Arighi A; Baker M; Benussi L; Bessi V; Binetti G; Blackburn DJ; Boada M; Boeve BF; Borrego-Ecija S; Borroni B; Bråthen G; Brooks WS; Bruni AC; Caroppo P; Bandres-Ciga S; Clarimon J; Colao R; Cruchaga C; Danek A; de Boer SC; de Rojas I; di Costanzo A; Dickson DW; Diehl-Schmid J; Dobson-Stone C; Dols-Icardo O; Donizetti A; Dopper E; Durante E; Ferrari C; Forloni G; Frangipane F; Fratiglioni L; Kramberger MG; Galimberti D; Gallucci M; García-González P; Ghidoni R; Giaccone G; Graff C; Graff-Radford NR; Grafman J; Halliday GM; Hernandez DG; Hjermind LE; Hodges JR; Holloway G; Huey ED; Illán-Gala I; Josephs KA; Knopman DS; Kristiansen M; Kwok JB; Leber I; Leonard HL; Libri I; Lleo A; Mackenzie IR; Madhan GK; Maletta R; Marquié M; Maver A; Menendez-Gonzalez M; Milan G; Miller BL; Morris CM; Morris HR; Nacmias B; Newton J; Nielsen JE; Nilsson C; Novelli V; Padovani A; Pal S; Pasquier F; Pastor P; Perneczky R; Peterlin B; Petersen RC; Piguet O; Pijnenburg YA; Puca AA; Rademakers R; Rainero I; Reus LM; Richardson AM; Riemenschneider M, 2024, 'Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia', American Journal of Human Genetics, 111, pp. 1316 - 1329, http://dx.doi.org/10.1016/j.ajhg.2024.05.017

Prusiner SB; Woerman AL; Mordes DA; Watts JC; Rampersaud R; Berry DB; Patel S; Oehler A; Lowe JK; Kravitz SN; Geschwind DH; Glidden DV; Halliday GM; Middleton LT; Gentleman SM; Grinberg LT; Giles K, 2024, 'Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism (vol 112, pg E5308, 2015)', PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 121, http://dx.doi.org/10.1073/pnas.2408899121

Valentino RR; Scotton WJ; Roemer SF; Lashley T; Heckman MG; Shoai M; Martinez-Carrasco A; Tamvaka N; Walton RL; Baker MC; Macpherson HL; Real R; Soto-Beasley AI; Mok K; Revesz T; Christopher EA; DeTure M; Seeley WW; Lee EB; Frosch MP; Molina-Porcel L; Gefen T; Redding-Ochoa J; Ghetti B; Robinson AC; Kobylecki C; Rowe JB; Beach TG; Teich AF; Keith JL; Bodi I; Halliday GM; Gearing M; Arzberger T; Morris CM; White CL; Mechawar N; Boluda S; MacKenzie IR; McLean C; Cykowski MD; Wang SHJ; Graff C; Nagra RM; Kovacs GG; Giaccone G; Neumann M; Ang LC; Carvalho A; Morris HR; Rademakers R; Hardy JA; Dickson DW; Rohrer JD; Ross OA; Warner TT; Jaunmuktane Z; Boeve BF; Duara R; Graff-Radford NR; Josephs KA; Knopman DS; Koga S; Murray ME; Lyons KE; Pahwa R; Petersen RC; Whitwell JL; Grinberg LT; Miller B; Schlereth A; Spina S; Grossman M; Irwin DJ; Suh ER; Trojanowski JQ; Van Deerlin VM; Wolk DA; Connors TR; Dooley PM; Oakley DH; Aldecoa I; Balasa M; Gelpi E; Borrego-Écija S; Gascon-Bayarri J; Sánchez-Valle R; Sanz-Cartagena P; Piñol-Ripoll G; Bigio EH; Flanagan ME; Rogalski EJ; Weintraub S; Schneider JA; Peng L; Zhu X; Chang K; Troncoso JC; Prokop S; Newell KL, 2024, 'MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study', The Lancet Neurology, 23, pp. 487 - 499, http://dx.doi.org/10.1016/S1474-4422(24)00083-8

Lok HC; Halliday GM; Kim WS, 2024, 'ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases', Neural Regeneration Research, 19, pp. 721 - 722, http://dx.doi.org/10.4103/1673-5374.382239

Marras C; Fereshtehnejad SM; Berg D; Bohnen NI; Dujardin K; Erro R; Espay AJ; Halliday G; Van Hilten JJ; Hu MT; Jeon B; Klein C; Leentjens AFG; Mollenhauer B; Postuma RB; Rodríguez-Violante M; Simuni T; Weintraub D; Lawton M; Mestre TA, 2024, 'Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach', Movement Disorders, 39, pp. 462 - 471, http://dx.doi.org/10.1002/mds.29708

de Boer SCM; Riedl L; Fenoglio C; Rue I; Landin-Romero R; Matis S; Chatterton Z; Galimberti D; Halliday G; Diehl-Schmid J; Piguet O; Pijnenburg YAL; Ducharme S, 2024, 'Rationale and Design of the “DIagnostic and Prognostic Precision Algorithm for behavioral variant Frontotemporal Dementia” (DIPPA-FTD) Study: A Study Aiming to Distinguish Early Stage Sporadic FTD from Late-Onset Primary Psychiatric Disorders', Journal of Alzheimer's Disease, 97, pp. 963 - 973, http://dx.doi.org/10.3233/JAD-230829

Kulisevsky J; Litvan I; Weintraub D; Goldman JG; Tröster AI; Lewis SJG; Adler C; Alves G; Amami P; Anderson T; Barker R; Barone P; Bezdicek O; Biundo R; Breen D; Burn D; Camacho M; Cammisuli D; Caviness J; Cecilia R; Cholerton B; Dalrymple-Alford J; de Bie R; Duff-Canning S; Eslinger P; Farrer M; Gasca-Salas C; Geurtsen G; Gunzler S; Halliday G; Huang X; Bilbao NI; Leverenz J; Marras C; Matar E; Mollenhauer B; Junque C; Pedersen K; Ricciardi L; Rodríguez-Oroz M; Santangelo G; Schiehser D; Segura B; Weil R; Williams-Gray C; Wu RMR; Yarnall A; Yu RL; Zabetian C, 2024, 'A Call for Change: Updating the Operational Definition for Dementia in Parkinson's Disease', Movement Disorders Clinical Practice, http://dx.doi.org/10.1002/mdc3.14305

Devenney EM; Tse NY; O’Callaghan C; Kumfor F; Ahmed RM; Caga J; Hazelton JL; Carrick J; Halliday GM; Piguet O; Kiernan MC; Hodges JR, 2024, 'An attentional and working memory theory of hallucination vulnerability in frontotemporal dementia', Brain Communications, 6, http://dx.doi.org/10.1093/braincomms/fcae123

Kavanagh T; Balcomb K; Ahmadi Rastegar D; Lourenco GF; Wisniewski T; Halliday G; Drummond E, 2024, 'hnRNP A1, hnRNP A2B1, and hnRNP K are dysregulated in tauopathies, but do not colocalize with tau pathology', Brain Pathology, http://dx.doi.org/10.1111/bpa.13305

Yang Y; Kim WS; Michaelian JC; Lewis SJG; Phillips CL; D'Rozario AL; Chatterjee P; Martins RN; Grunstein R; Halliday GM; Naismith SL, 2024, 'Predicting neurodegeneration from sleep related biofluid changes', Neurobiology of Disease, 190, http://dx.doi.org/10.1016/j.nbd.2023.106369

Valentino RR; Scotton WJ; Roemer SF; Lashley T; Heckman MG; Shoai M; Martinez-Carrasco A; Tamvaka N; Walton RL; Baker MC; Macpherson HL; Real R; Soto-Beasley A; Mok K; Revesz T; Christopher EA; Deture M; Seeley WW; Lee EB; Frosch MP; Molina-Porcel L; Gefen T; Redding-Ochoa J; Ghetti B; Robinson AC; Kobylecki C; Rowe JB; Beach TG; Teich AF; Keith JL; Bodi I; Halliday GM; Gearing M; Arzberger T; Morris CM; White CL; Mechawar N; Boluda S; MacKenzie IR; McLean C; Cykowski M; Wang S-HJ; Graff C; Nagra RM; Kovacs GG; Giaccone G; Neumann M; Ang L-C; Carvalho A; Morris HR; Rademakers R; Hardy JA; Dickson DW; Rohrer JD; Ross OA, 2024, 'MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study', LANCET NEUROLOGY, 23, pp. 487 - 499

Guennewig B; Lim J; Marshall L; McCorkindale AN; Paasila PJ; Patrick E; Kril JJ; Halliday GM; Cooper AA; Sutherland GT, 2023, 'Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology (Scientific Reports, (2021), 11, 1, (4865), 10.1038/s41598-021-83872-z)', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-36807-9

Marian OC; Teo JD; Lee JY; Song H; Kwok JB; Landin-Romero R; Halliday G; Don AS, 2023, 'Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01544-7

Lok HC; Katzeff JS; Hodges JR; Piguet O; Fu YH; Halliday GM; Kim WS, 2023, 'Elevated GRO-α and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-35945-4

Youssef P; Hughes L; Kim WS; Halliday GM; Lewis SJG; Cooper A; Dzamko N, 2023, 'Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-32480-0

Pavan C; Jin J; Jong S; Strbenac D; Davis RL; Sue CM; Johnston J; Lynch T; Halliday G; Kirik D; Parish CL; Thompson LH; Ovchinnikov DA, 2023, 'Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene', Stem Cell Research, 73, http://dx.doi.org/10.1016/j.scr.2023.103211

Tan RH; McCann H; Shepherd CE; Pinkerton M; Mazumder S; Devenney EM; Adler GL; Rowe DB; Kril J; Halliday GM; Kiernan MC, 2023, 'Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01670-2

Chatterton Z; Lamichhane P; Ahmadi Rastegar D; Fitzpatrick L; Lebhar H; Marquis C; Halliday G; Kwok JB, 2023, 'Single-cell DNA methylation sequencing by combinatorial indexing and enzymatic DNA methylation conversion', Cell and Bioscience, 13, http://dx.doi.org/10.1186/s13578-022-00938-9

Kiernan MC; Halliday GM; Rowe DB; Tan RH, 2023, 'The importance of patient-centred drug development for amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12944

Shepherd CE; Lewis SJG; Tisch S; Mccann H; Jonker B; Halliday GM, 2023, 'Effects of STN/SNr deep brain stimulation in a case of progressive supranuclear palsy with a Parkinson disease phenotype', Journal of Neuropathology and Experimental Neurology, 82, pp. 821 - 823, http://dx.doi.org/10.1093/jnen/nlad052

Pinkerton M; Lourenco G; Pacheco MT; Halliday GM; Kiernan MC; Tan RH, 2023, 'Survival in sporadic ALS is associated with lower p62 burden in the spinal cord', Journal of Neuropathology and Experimental Neurology, 82, pp. 769 - 773, http://dx.doi.org/10.1093/jnen/nlad051

Qi R; Sammler E; Gonzalez-Hunt CP; Barraza I; Pena N; Rouanet JP; Naaldijk Y; Goodson S; Fuzzati M; Blandini F; Erickson KI; Weinstein AM; Lutz MW; Kwok JB; Halliday GM; Dzamko N; Padmanabhan S; Alcalay RN; Waters C; Hogarth P; Simuni T; Smith D; Marras C; Tonelli F; Alessi DR; West AB; Shiva S; Hilfiker S; Sanders LH, 2023, 'A blood-based marker of mitochondrial DNA damage in Parkinson's disease', Science Translational Medicine, 15, http://dx.doi.org/10.1126/SCITRANSLMED.ABO1557

Affleck AJ; Sachdev PS; Halliday GM, 2023, 'Past antihypertensive medication use is associated with lower levels of small vessel disease and lower Aβ plaque stage in the brains of older individuals', Neuropathology and Applied Neurobiology, 49, pp. e12922, http://dx.doi.org/10.1111/nan.12922

Back to profile page